pharmaceutical
Roche’s 99% accurate Zika test receives FDA approval
October 9, 2017Sales and Marketing Roche, Zika, biotech, drugs, pharma, pharmaceutical
Roche has revealed that the FDA has given approval to its cobas Zika test to determine whether a blood sample …
Trump sweeps away birth control coverage
October 9, 2017Medical Communications, Sales and Marketing President trump, Trump, biotech, birth control, drugs, pharma, pharmaceutical
Part of Obama’s Affordable Care Act included the provision that employer-provided health insurance must cover birth control, President Trump has …
Battery implant approved to treat sleep apnea
October 9, 2017Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical
The FDA has announced the approval of a new form of treatment for central sleep apnea, in the form of …
Sanofi promotes global head of diabetes to expand role
October 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical
Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …
AbbVie hit with $140m fine over fraudulent marketing of Androgel
October 6, 2017Medical Communications, Sales and Marketing AbbVie, androgel, biotech, drugs, pharma, pharmaceutical
AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …
Bayer forced to halt huge study into key drug
October 6, 2017Medical Communications, Research and Development Bayer, Janssen, Xarelto, biotech, drugs, pharma, pharmaceutical
Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …
South Africa’s over-charging case against Aspen dissolves, remains against big names
October 6, 2017Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical
South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …
Merck KGaA promotes from within new MEA head
October 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, …
UK High Court rejects ABPI’s challenge to new NICE cost curbs
October 5, 2017Sales and Marketing ABPI, NHS, NHS England, NICE, legal, pharma, pharmaceutical
The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …
Gonorrhoea is just the tip of the antimicrobial resistance iceberg
October 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NovaBiotics, biotech, drugs, gonorrhoea, pharma, pharmaceutical
Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …
KSQ Therapeutics emerges from shadows, with former Genzyme CEO at helm
October 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meeker, KSQ Therapeutics, biotech, drugs, pharma, pharmaceutical
KSQ Therapeutics has been known of for the last two years, when it was originally founded, but now it has …
England set to adopt opt-out organ donation
October 5, 2017Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical
In a major change for the healthcare system in England, admittedly one that was easy to be lost among the …
57% of cancer drugs uses approved by EMA show no benefit
October 5, 2017Sales and Marketing EMA, biotech, drugs, oncology, pharma, pharmaceutical
A new study conducted by King’s College London and LSE has found that of 48 treatments approved between 2009 and …
Mylan receives shock approval of Teva blockbuster
October 5, 2017Sales and Marketing Copaxone, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Mylan had been knocked back by the FDA in its quest to have its generic version of Copaxone approved earlier …
CytomX scores deal with Amgen worth potential $1.5bn
October 4, 2017Research and Development, Sales and Marketing Amgen, biotech, cytomx, drugs, pharma, pharmaceutical
CytomX Therapeutics and Amgen have signed a deal that could be worth a potential $1.5 billion. The agreement will see …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
